BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 30885303)

  • 1. Attenuated Salmonella secreting Brucella protective antigens confer dual-faceted protection against brucellosis and salmonellosis in a mouse model.
    Senevirathne A; Hewawaduge C; Lee JH
    Vet Immunol Immunopathol; 2019 Mar; 209():31-36. PubMed ID: 30885303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Live vaccine consisting of attenuated Salmonella secreting and delivering Brucella ribosomal protein L7/L12 induces humoral and cellular immune responses and protects mice against virulent Brucella abortus 544 challenge.
    Senevirathne A; Hewawaduge C; Lee JH
    Vet Res; 2020 Jan; 51(1):6. PubMed ID: 31973749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination of goats with a combination
    Leya M; Kim WK; Cho JS; Yu EC; Kim YJ; Yeo Y; Lyoo KS; Yang MS; Han SS; Lee JH; Tark D; Hur J; Kim B
    J Vet Sci; 2018 Sep; 19(5):643-652. PubMed ID: 29929362
    [No Abstract]   [Full Text] [Related]  

  • 4. Brucella lipopolysaccharide reinforced Salmonella delivering Brucella immunogens protects mice against virulent challenge.
    Lalsiamthara J; Lee JH
    Vet Microbiol; 2017 Jun; 205():84-91. PubMed ID: 28622869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of immunization routes and protective efficacy of
    Lalsiamthara J; Won G; Lee JH
    J Vet Sci; 2018 May; 19(3):416-425. PubMed ID: 29366302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective efficacy of attenuated
    Leya M; Kim WK; Ochirkhuyag E; Yu EC; Kim YJ; Yeo Y; Yang MS; Han SS; Lee JH; Tark D; Hur J; Kim B
    J Vet Sci; 2021 Mar; 22(2):e15. PubMed ID: 33774931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of mice from Brucella infection by immunization with attenuated Salmonella enterica serovar typhimurium expressing A L7/L12 and BLS fusion antigen of Brucella.
    Zhao Z; Li M; Luo D; Xing L; Wu S; Duan Y; Yang P; Wang X
    Vaccine; 2009 Aug; 27(38):5214-9. PubMed ID: 19596411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasally administered anti-Brucella subunit vaccine formulation induces protective immune responses against nasal Brucella challenge.
    Senevirathne A; Hewawaduge C; Hajam IA; Lalsiamthara J; Lee JH
    Vet Microbiol; 2019 Jan; 228():112-118. PubMed ID: 30593355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immuno-profiles of BALB/c mice inoculated with Salmonella vector delivering B-cell mitogen hydroxyproline epimerase.
    Lalsiamthara J; Lee JH
    Mol Immunol; 2018 Mar; 95():114-121. PubMed ID: 29433066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
    Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of sodium bicarbonate- and magnesium hydroxide-based gastric antacids for the effectiveness of Salmonella delivered Brucella antigens against wild type challenge in BALB/c mice.
    Hewawaduge C; Senevirathne A; Yang MS; Jeong TW; Kim B; Lee JH
    Pathog Dis; 2021 Feb; 79(2):. PubMed ID: 33527985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization of BALB/c mice with a combination of four recombinant Brucella abortus proteins, AspC, Dps, InpB and Ndk, confers a marked protection against a virulent strain of Brucella abortus.
    Hop HT; Arayan LT; Huy TXN; Reyes AWB; Min W; Lee HJ; Park SJ; Chang HH; Kim S
    Vaccine; 2018 May; 36(21):3027-3033. PubMed ID: 29678458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant outer membrane protein 25c from Brucella abortus induces Th1 and Th2 mediated protection against Brucella abortus infection in mouse model.
    Paul S; Peddayelachagiri BV; Nagaraj S; Kingston JJ; Batra HV
    Mol Immunol; 2018 Jul; 99():9-18. PubMed ID: 29649688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization.
    Abkar M; Lotfi AS; Amani J; Eskandari K; Ramandi MF; Salimian J; Brujeni GN; Alamian S; Kamali M; Koushki H
    Vet Res Commun; 2015 Dec; 39(4):217-28. PubMed ID: 26395469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge.
    Rajasekaran P; Surendran N; Seleem MN; Sriranganathan N; Schurig GG; Boyle SM
    Vaccine; 2011 Apr; 29(17):3106-10. PubMed ID: 21376799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Booster vaccination with safe, modified, live-attenuated mutants of Brucella abortus strain RB51 vaccine confers protective immunity against virulent strains of B. abortus and Brucella canis in BALB/c mice.
    Truong QL; Cho Y; Kim K; Park BK; Hahn TW
    Microbiology (Reading); 2015 Nov; 161(11):2137-48. PubMed ID: 26341622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brucella abortus 2308ΔNodVΔNodW double-mutant is highly attenuated and confers protection against wild-type challenge in BALB/c mice.
    Li Z; Wang S; Zhang J; Yang G; Yuan B; Huang J; Han J; Xi L; Xiao Y; Chen C; Zhang H
    Microb Pathog; 2017 May; 106():30-39. PubMed ID: 28131952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
    Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
    Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization of guinea pigs with Salmonella delivered anti-Brucella formulation reduces organs bacterial load and mitigates histopathological consequences of Brucella abortus 544 challenge.
    Lalsiamthara J; Lee JH
    Vet Immunol Immunopathol; 2018 Jan; 195():40-45. PubMed ID: 29249316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of host infectivity, immunity, and protective efficacy by addition of sodium bicarbonate antacid to oral vaccine formulation of live attenuated Salmonella secreting Brucella antigens.
    Hewawaduge C; Senevirathne A; Lee JH
    Microb Pathog; 2020 Jan; 138():103857. PubMed ID: 31705999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.